January 22, 2021
Welcome to today's edition of The Reader, a weekly roundup of our stories and insights.
Joe Biden has officially been sworn in as the 46th President of the United States. Here's what his presidency means for the business world.
Read on for more stories. Clifton Leaf MUST READ Biden's not done signing executive orders—here's his agenda for the next 9 days
A flurry of further executive orders is expected to follow, according to a memo sent out Saturday by White House chief of staff Ron Klain.
BY ARIC JENKINS JANUARY 21, 2021
The S&P 500's performance on Wednesday—when it closed up almost 1.4%—was the largest Inauguration Day pop since 1985. BY ANNE SRADERS JANUARY 21, 2021
Put simply, what Biden is proposing amounts to one of the most daring wagers ever in U.S. economic policy. BY SHAWN TULLY JANUARY 18, 2021
Some promoted new conspiracy theories that suggested the battle for the White House wasn't over. BY DANIELLE ABRIL JANUARY 20, 2021
MUST WATCH What a Biden administration will mean for the business world
Fortune's Geoff Colvin explains why Joe Biden's presidency will be a mixed blessing for the business world.
Here's a peek at Fortune Analytics, our exclusive newsletter for Premium subscribers that brings you weekly business insights based on timely data analysis by our editorial team and exclusive polling.
This week, we polled 2,554 U.S. adults on their sentiments towards Big Tech.
64%
48%
52%
To get the full briefing, consider becoming a Fortune Premium subscriber. You'll also get access to all of our stories on the web and in print.
Your support makes our journalism possible. Thank you.
More essential reads
A note from Fortune
What you need to know in this moment of change Unlock market insights from leading experts and news analysis that gives you an edge. Save 40% with an annual premium subscription.
From the archives
"The most common vaccine production method uses chicken eggs. This process takes about five months, according to GlaxoSmithKline. Millions of fertilized eggs are used as a culture to grow influenza viruses, which are then harvested, purified and packaged into vials. Manufacturers and the FDA then test for potency and safety before shipping the lot releases around the country.
This method has been in practice since the 1950s. It's slow and tedious, especially given the challenges. Firstly, manufacturing relies on the availability of enough fertilized eggs. If egg supplies were ever compromised it would affect our ability to produce enough serum. Second, some flu strains don't grow that well in chicken eggs and undergo undesirable mutations that affect the potency of a seasonal vaccine." —After 70 years, why aren't we better at developing flu vaccines?, Laura Lorenzetti, February 2015
This email was sent to acozocom.news01@blogger.com Unsubscribe | Edit your newsletter subscriptions
Did someone share this with you? Subscribe here.
Fortune Media (USA) Corporation 40 Fulton Street New York, NY. 10038 |
Friday, January 22, 2021
Here's Biden's plan for the week ahead
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment